School Located Adolescent Vaccination Study

December 31, 2012 updated by: University of Colorado, Denver

Examination of the Effectiveness of Adolescent Vaccines Given in Schools

The provision of adolescent vaccination in a school setting will be feasible and acceptable to parents as evidenced by the number and percentage of students immunized within each school compared to those in schools without a program. The likelihood of vaccination for diphtheria, tetanus, and pertussis (Tdap), human papillomavirus (HPV), and meningococcal conjugate vaccine (MCV4) and all three combined) among eligible students enrolled in schools with a comprehensive school-based immunization program will be significantly higher than that of students enrolled in schools without a school-based immunization program.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

2000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Denver
      • Denver, Colorado, United States, 80231
        • Kaiser Permanente Colorado

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 2000 (1000 at intervention schools and 1000 in control schools) randomly selected students enrolled in 6th - 8th grade at randomly selected schools
  • students who appear to be in need of one or more immunizations of interest at the beginning of the school year
  • students enrolled in school by October 1st registration deadline will be included in the analysis

Exclusion Criteria:

  • students who appear to have had all immunizations of interest at the beginning of the school year
  • students enrolled after the October 1 school registration deadline will be excluded from the analysis
  • students enrolled in grades other than 6th, 7th, or 8th grade will not be eligible to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: School Located Vaccine (SLV) Program
A vaccine program carried out by a community vaccinator will be conducted in a limited number of participating schools. The program will be open to the students enrolled at the participating schools
A community vaccinator will administer vaccines to students whose parents consent for their child to participate
No Intervention: no School Located Vaccine (SLV) Program
Schools that are part of the non-intervention arm of the study will not have a school-located vaccine program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The likelihood of vaccination among eligible 6th grade students with one or more needed vaccines in intervention schools compared to control schools.
Time Frame: end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The vaccination status of eligible students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings.
end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The likelihood of vaccination among eligible 6th grade students with Tdap vaccine in intervention schools compared to control schools.
Time Frame: end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The Tdap vaccination status of eligible students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings.
end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The likelihood of vaccination among eligible 6th grade students with MCV4 vaccine in intervention schools compared to control schools.
Time Frame: end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The MCV4 vaccination status of eligible students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings.
end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The likelihood of vaccination among eligible 6th grade female students with HPV vaccine in intervention schools compared to control schools.
Time Frame: end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The HPV vaccination status of eligible female students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings.
end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The likelihood of vaccination with Tdap vaccine among eligible 7th and 8th grade students enrolled at intervention schools compared to control schools.
Time Frame: end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The Tdap vaccination status of students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings.
end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The likelihood of vaccination with one or more HPV vaccines among eligible 7th and 8th grade female students enrolled in intervention schools compared to control schools.
Time Frame: end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The HPV vaccination status of eligible female students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings.
end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The likelihood of MCV4 vaccination among eligible 7th and 8th students enrolled in intervention schools compared to control schools.
Time Frame: end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The MCV4 vaccination status of eligible 7th and 8th grade students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings.
end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The likelihood of HPV vaccine series completion among female students in intervention schools compared to control schools.
Time Frame: end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011
The HPV vaccine status of female students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings.
end of the school year 2010 - 2011 compared to beginning of school year 2010 - 2011

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Judy Shlay, MD, MSPH, Denver Public Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2010

Primary Completion (Actual)

August 1, 2011

Study Completion (Actual)

October 1, 2011

Study Registration Dates

First Submitted

October 30, 2012

First Submitted That Met QC Criteria

October 30, 2012

First Posted (Estimate)

November 1, 2012

Study Record Updates

Last Update Posted (Estimate)

January 3, 2013

Last Update Submitted That Met QC Criteria

December 31, 2012

Last Verified

September 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • 08-0204

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on School Located Vaccine Program

Clinical Trials on School Located Vaccine (SLV) Program

Subscribe